These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12840793)

  • 1. When can empiric therapy for intensive care unit-acquired pneumonia be withheld or withdrawn?
    Koeman M; Bonten MJ
    Semin Respir Infect; 2003 Jun; 18(2):122-8. PubMed ID: 12840793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nosocomial pneumonia in the intensive care unit: controversies and dilemmas.
    Mehta RM; Niederman MS
    J Intensive Care Med; 2003; 18(4):175-88. PubMed ID: 15035764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ventilator-associated pneumonia and multiresistant bacteria].
    Heininger A; Unertl K
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Feb; 42(2):122-9. PubMed ID: 17309020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A practical application of practice-based learning: development of an algorithm for empiric antibiotic coverage in ventilator-associated pneumonia.
    Miller PR; Partrick MS; Hoth JJ; Meredith JW; Chang MC
    J Trauma; 2006 Apr; 60(4):725-9; discussion 729-31. PubMed ID: 16612290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in inadequate empiric antibiotic therapy for ventilator-associated pneumonia: impact of a unit-specific treatment pathway.
    Magnotti LJ; Schroeppel TJ; Fabian TC; Clement LP; Swanson JM; Fischer PE; Bee TK; Maish GO; Minard G; Zarzaur BL; Croce MA
    Am Surg; 2008 Jun; 74(6):516-22; discussion 522-3. PubMed ID: 18556994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
    Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
    Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is ventilator-associated pneumonia and why is it important?
    Kollef MH
    Respir Care; 2005 Jun; 50(6):714-21; discussion 721-4. PubMed ID: 15913464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventilator-associated pneumonia: a review.
    Joseph NM; Sistla S; Dutta TK; Badhe AS; Parija SC
    Eur J Intern Med; 2010 Oct; 21(5):360-8. PubMed ID: 20816584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventilator-associated pneumonia: what is new?
    Chastre J
    Surg Infect (Larchmt); 2006; 7 Suppl 2():S81-5. PubMed ID: 16895514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
    Shorr AF; Combes A; Kollef MH; Chastre J
    Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal threshold for diagnosis of ventilator-associated pneumonia using bronchoalveolar lavage.
    Miller PR; Meredith JW; Chang MC
    J Trauma; 2003 Aug; 55(2):263-7; discussion 267-8. PubMed ID: 12913635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems.
    Kollef MH
    Respir Care; 2004 Dec; 49(12):1530-41. PubMed ID: 15571647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes.
    Teixeira PJ; Seligman R; Hertz FT; Cruz DB; Fachel JM
    J Hosp Infect; 2007 Apr; 65(4):361-7. PubMed ID: 17350721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention.
    Safdar N; Crnich CJ; Maki DG
    Respir Care; 2005 Jun; 50(6):725-39; discussion 739-41. PubMed ID: 15913465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and innovative strategies to treat ventilator-associated pneumonia: optimizing the duration of therapy and nebulizing antimicrobial agents.
    Goldstein I; Chastre J; Rouby JJ
    Semin Respir Crit Care Med; 2006 Feb; 27(1):82-91. PubMed ID: 16508884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventilator-associated pneumonia.
    Vincent JL
    J Hosp Infect; 2004 Aug; 57(4):272-80. PubMed ID: 15262388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial treatment of ventilator-associated pneumonia.
    Park DR
    Respir Care; 2005 Jul; 50(7):932-52; discussion 952-5. PubMed ID: 15972114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.
    Depuydt PO; Blot SI; Benoit DD; Claeys GW; Verschraegen GL; Vandewoude KH; Vogelaers DP; Decruyenaere JM; Colardyn FA
    Crit Care Med; 2006 Mar; 34(3):653-9. PubMed ID: 16505649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value of preliminary bacterial colony counts from bronchoalveolar lavage in critically ill trauma patients.
    Mueller EW; Wood GC; Kelley MS; Boucher BA; Fabian TC; Croce MA
    Am Surg; 2003 Sep; 69(9):749-55; discusiion 755-6. PubMed ID: 14509321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.